Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-830216 (Pro-Drug of BMS-819881) in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs BMS 830216 (Primary)
- Indications Obesity
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 07 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2009 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.